Job description: We use science to save lives, and so can you. We are currently recruiting for a Senior Client Project Manager. The purpose of this role is to manage the relationship between OXB and its Clients and ensure projects are delivered on time and within budget to the required quality to ensure successful long-term alliances. OXB’s Client Programme Management team ensure delivery of Process Development and Manufacturing technical projects for our customers. Your responsibilities in this role will include: Maintain client / partner satisfaction to ensure successful long-term alliances. Understand client needs and identify ongoing project opportunities. Ensure projects are delivered within the agreed scope, timeline and budget and project milestones are met. Ensure project risks are identified, and effective mitigation actions are put in place. Provide project updates and performance data to OXB (Oxford Biomedica) Management to enable effective strategic and tactical decision making. Responsibility for all financial aspects of the collaboration including forecasting, cost control etc. Determine scope, costings, and timelines for new work packages. Assist with preparing proposals and contribute to contract negotiations for prospective clients. We are looking for: A degree within Life Sciences or other similar. A project management qualification would be advantageous. Good technical understanding of biopharmaceutical process development and GMP manufacturing, ideally from working in this field. Previous project management experience. Knowledge of Project Management tools, methodologies & techniques. Experience of working to external client deliverables. Experience of managing projects using MS Project & MS Excel. Good interpersonal skills with the ability to collaborate and influence. About Us: OXB is a quality and innovation-led viral vector CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies. OXB collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. OXB’s world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods, and depth of regulatory expertise. What’s in it for you: Highly competitive total reward packages Wellbeing programmes Development opportunities Welcoming, friendly, supportive colleagues A diverse and inclusive working environment Our values are: Responsible, Responsive, Resilient, Respect State of the art laboratory and manufacturing facilities We want you to feel inspired every day. We’re future-focused and our business is growing rapidly. We succeed together through passion, commitment and teamwork, and so can you. Collaborate. Contribute. Change lives Profile description: We are looking for: A degree within Life Sciences or other similar. A project management qualification would be advantageous. Good technical understanding of biopharmaceutical process development and GMP manufacturing, ideally from working in this field. Previous project management experience. Knowledge of Project Management tools, methodologies & techniques. Experience of working to external client deliverables. Experience of managing projects using MS Project & MS Excel. Good interpersonal skills with the ability to collaborate and influence. About Us: OXB is a quality and innovation-led viral vector CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies. OXB collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. OXB’s world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods, and depth of regulatory expertise. What’s in it for you: Highly competitive total reward packages Wellbeing programmes Development opportunities Welcoming, friendly, supportive colleagues A diverse and inclusive working environment Our values are: Responsible, Responsive, Resilient, Respect State of the art laboratory and manufacturing facilities We want you to feel inspired every day. We’re future-focused and our business is growing rapidly. We succeed together through passion, commitment and teamwork, and so can you. Collaborate. Contribute. Change lives We offer: Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies. Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patient’s cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients’ cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy). Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.